The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre- versus postoperative CAPOX plus bevacizumab (CAPOX-Bev) for resectable liver metastases from colorectal cancer (CLM): A randomized phase II/III trial (HiSCO-01).
 
Yuji Takakura
No Relationships to Disclose
 
Katsunori Shinozaki
Honoraria - Asahi Kasei; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly; Merck; Mochida Pharmaceutical Co. Ltd.; Nihonkayaku; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda
 
Satoshi Ikeda
No Relationships to Disclose
 
Hiroyuki Egi
No Relationships to Disclose
 
Yuzo Hirata
No Relationships to Disclose
 
Manabu Shimomura
No Relationships to Disclose
 
Takafumi Oshiro
No Relationships to Disclose
 
Takao Hinoi
Speakers' Bureau - Lilly Japan; Merck KGaA; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma
 
Daisuke Sumitani
No Relationships to Disclose
 
Masahiro Nakahara
No Relationships to Disclose
 
Masanori Yoshimitsu
No Relationships to Disclose
 
Naruhiko Honmyo
No Relationships to Disclose
 
Tsuyoshi Kobayashi
No Relationships to Disclose
 
Hideki Ohdan
No Relationships to Disclose